These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 3240935)

  • 1. Immunogenicity of hepatitis B vaccine in healthy Malaysian adults.
    Ton SH; Noriah R; Duraisamy G
    Indian J Med Res; 1988 Jun; 87():542-4. PubMed ID: 3240935
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunogenicity and tolerance of a combined hepatitis A/B vaccine. Preliminary results with a candidate vaccine].
    Kallinowski B; Bock HL; Clemens R; Theilmann L
    Dtsch Med Wochenschr; 1995 Oct; 120(42):1426-9. PubMed ID: 7555671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to hepatitis B vaccination in haemodialysis patients and healthy medical staff.
    Ton SH; Duraisamy G; Noriah R; Thiruselvam A; Lopez CG; Suleiman AB
    Singapore Med J; 1986 Apr; 27(2):120-3. PubMed ID: 2944217
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vaccination against viral hepatitis A and B in adults aged over 40 years--antibody persistence and immune memory].
    Chlibek R; Smetana J; Bostíková V; Splino M
    Epidemiol Mikrobiol Imunol; 2011 Sep; 60(3):99-108. PubMed ID: 22132651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of immunogenicity of an inactivated hepatitis A vaccine in anti-HIV positive and negative hemophilic patients.
    Santagostino E; Gringeri A; Rocino A; Zanetti A; de Biasi R; Mannucci PM
    Thromb Haemost; 1994 Oct; 72(4):508-10. PubMed ID: 7878624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of Engerix-B in healthy Malaysian medical students.
    Isahak I; Abdul Malik Y; Hakim AS; Baharin R
    Singapore Med J; 1990 Aug; 31(4):314-6. PubMed ID: 2147781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease.
    Keeffe EB; Iwarson S; McMahon BJ; Lindsay KL; Koff RS; Manns M; Baumgarten R; Wiese M; Fourneau M; Safary A; Clemens R; Krause DS
    Hepatology; 1998 Mar; 27(3):881-6. PubMed ID: 9500723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Duration of the immunoprophylaxis produced by hepatitis B vaccine].
    Hernández JM; Piqueras J; Esteban JI; Esteban R
    Med Clin (Barc); 1985 May; 84(17):714-5. PubMed ID: 4010375
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of the hepatitis B virus-neutralizing response in acute infection and in patients vaccinated against the infection].
    Pontisso P; Schiavon E; Stenico D; Chemello L; Fraiese A; Pasquali C; Alberti A
    Recenti Prog Med; 1986 Nov; 77(11):508-10. PubMed ID: 3027797
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis A vaccination.
    Tong MJ; Co RL; Bellak C
    West J Med; 1993 Jun; 158(6):602-5. PubMed ID: 8393253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two dose combined hepatitis A and B vaccine in Chinese youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A
    J Med Virol; 1999 Sep; 59(1):1-4. PubMed ID: 10440800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term observation on the immunogenicity of hepatitis B vaccine in infants and adults].
    Hayashi J; Kashiwagi S; Nomura H; Kajiyama W; Ikematsu H; Shingu T
    Kansenshogaku Zasshi; 1986 Jul; 60(7):659-65. PubMed ID: 3097205
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis B vaccine: extending immunogenicity.
    Horton RC
    Br J Hosp Med; 1990 Jun; 43(6):409. PubMed ID: 2364233
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatitis B markers in health service personnel with reference to preventive vaccination].
    Stempień R; Małolepsza E; Jabłkowski M; Bielicka G; Górski T
    Pol Tyg Lek; 1988 Jul; 43(29):942-4. PubMed ID: 3237528
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunogenicity and stability of an aluminum-free liposomal hepatitis A vaccine (Epaxal Berna)].
    Wegmann A; Zellmeyer M; Glück R; Finkel B; Flückiger A; Berger R; Just M
    Schweiz Med Wochenschr; 1994 Nov; 124(45):2053-6. PubMed ID: 7973542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and reactogenicity of an inactivated hepatitis A vaccine in Indian adults.
    Das K; Jain A; Gupta RK; Kar P
    Natl Med J India; 1999; 12(6):268-9. PubMed ID: 10732428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune dysfunction in patients not responding to hepatitis B vaccination.
    Kitas GD; Salmon M; Emery P
    Lancet; 1989 Mar; 1(8637):551-2. PubMed ID: 2564077
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis B vaccine.
    Drug Ther Bull; 1985 Jul; 23(13):49-51. PubMed ID: 3160568
    [No Abstract]   [Full Text] [Related]  

  • 19. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients.
    Stark K; Günther M; Neuhaus R; Reinke P; Schröder K; Linnig S; Bienzle U
    J Infect Dis; 1999 Dec; 180(6):2014-7. PubMed ID: 10558960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.